Stock Price & Analysis

Based on the current market data and analyst insights, here's a concise analysis for CTVA:

Technical Analysis

The stock is currently trading at $62.66 with a modest gain of 0.51% in regular market trading. The stock is showing neutral RSI at 50.43, indicating balanced buying and selling pressure. The price is hovering around its 20-day moving average of $63.03, suggesting a consolidation phase.

Recent Developments & Analyst Views

• Q4 2024 results were strong with adjusted EPS of 32 cents, beating estimates of 31 cents
• The company provided FY25 guidance of $2.70-$2.95 operating EPS and net sales of $17.2-17.6 billion
• Multiple analysts have recently raised their price targets:
  • KeyBanc: $68 to $70
  • Oppenheimer: $70 to $72
  • RBC Capital: $72 to $73

Market Sentiment

• Current analyst consensus is Moderate Buy with average price target of $68.71, suggesting ~10% upside potential
• However, insider sentiment is negative with 73 insiders selling shares recently

Recommendation Based on the technical consolidation pattern, strong Q4 results, and positive analyst sentiment balanced against negative insider activity, holding CTVA at current levels is recommended. While the stock shows promise with multiple analyst upgrades, the current price point doesn't present a compelling entry for new positions.

Based on recent analyst reports and market data, here is the 2025 price prediction for CTVA stock:

CTVA stock is expected to reach $70-73 by end of 2025, representing approximately 12-16% upside from current levels, driven by strong demand for advanced seed technology and recovery in crop protection markets. Multiple analysts including RBC Capital, KeyBanc, and Oppenheimer have recently raised their price targets to this range following strong Q4 2024 results and improving agricultural fundamentals. The company's focus on cost optimization and new product launches, particularly in biologicals and spinosyns, provides additional support for this target.

The S1 support level for CTVA Stock is $61.47 ,The R1 resistant level for CTVA Stock is $65.27.

As of the end of day on 2025-02-14, the price of CTVA Stock was $63.81.

The target price for CTVA Stock according to analyst rating is 68.64, with the highest price target at 74.00 and the lowest at 57.00. Analysts have a Moderate Buy rating on CTVA Stock overall.

The market cap of CTVA is $43.9B.

Based on the provided data and recent market analysis, here's a comprehensive evaluation of CTVA's valuation:

Valuation Analysis CTVA appears to be fairly valued at current levels based on multiple metrics. The company trades at a P/E ratio of 47.97, which is elevated compared to historical averages but can be justified by expected earnings growth and market position.

Growth Prospects The company is projecting FY25 operating EPS of $2.70-$2.95, with analysts expecting 24.3% year-over-year EPS growth in fiscal 2025. This strong growth outlook supports the current valuation multiples.

Market Sentiment Wall Street maintains a positive view, with a consensus "Moderate Buy" rating and an average price target of $68.71, suggesting a 10.18% upside from current levels. Multiple analysts have recently raised their price targets:

• KeyBanc: $70 (from $68)
• Oppenheimer: $72 (from $70)
• RBC Capital: $73 (from $72)

Business Fundamentals

• Strong market position in seeds with Pioneer maintaining #1 position in corn and soybeans in US
• Enlist E3 soybeans reached 65% market penetration
• Achieved 20% operating EBITDA margin for the first time in 2024
• Solid cash flow generation with $1.7 billion in operating free cash flow

Risk Factors

• Insider sentiment is negative with 73 insiders selling shares recently
• Currency headwinds, particularly from Brazilian real
• Competitive pressures in key markets
• Market volatility in agricultural commodities

Based on these factors, CTVA appears to be appropriately valued at current levels, with its premium valuation supported by strong market position, growth prospects, and improving operational efficiency.

Corteva, Inc. is a global pure-play agriculture company. The Company is a global provider of seed and crop protection solutions focused on the agriculture industry and contributing to a healthier food supply. The Company's Seed segment is developing and supplying advanced germplasm and traits that produce optimum yield for farms around the world. The segment is engaged in the seed markets, such as North America corn and soybeans, Europe corn and sunflower, as well as Brazil, India, South Africa, and Argentina corn. The segment also offers trait technologies that improve resistance to weather, disease, insects and enhance food. The Company's Crop Protection segment offers crop protection solutions and digital solutions that provide farmers with the tools they need to improve productivity and profitability, and help keep fields free of weeds, insects and diseases. The segment offers herbicides, insecticides, nitrogen stabilizers, pasture and range management herbicides and biologicals.

Based on the provided data and recent analyst reports, here's a price prediction for CTVA stock by 2030:

Corteva (CTVA) stock is projected to reach $95-105 by 2030, driven by continued expansion in biologicals targeting $1 billion revenue, strong adoption of Enlist technology reaching 65% market penetration, and strategic cost optimization initiatives targeting $1 billion in productivity benefits by 2027. The company's focus on innovation with 300 new seed hybrids launches annually and growing demand for advanced agricultural solutions supports this growth trajectory.

The mid-term target of $1 billion EBITDA growth over 2025-2027 with 23-24% margins, combined with the company's strong market position in seeds and crop protection, suggests sustained long-term value creation potential through 2030.

CTVA has a total of 22500 employees.